Inside Drug Pricing - 03/02/2020

Coronavirus Outbreak Adds Urgency To Drug Pricing Debate

By John Wilkerson, Ariel Cohen / March 2, 2020 at 10:54 AM
Instead of overshadowing the drug pricing debate, the coronavirus outbreak is adding urgency to it. A win on drug pricing would help the president recover from criticism of his handling of the emerging threat, and the potential strain on the health care system could underscore the need for drug-pricing reforms. President Donald Trump tweeted over the weekend that he will meet with drug companies Monday (March 2) to discuss the status of vaccines and treatments for the 2019 novel coronavirus...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.